Lanctôt KL - Search Results

1

A placebo-controlled trial of valproate for agitation and aggression in Alzheimer's disease.

Herrmann N, Lanctôt KL, Rothenburg LS, Eryavec G. Herrmann N, et al. Among authors: lanctot kl. Dement Geriatr Cogn Disord. 2007;23(2):116-9. doi: 10.1159/000097757. Epub 2006 Dec 4. Dement Geriatr Cogn Disord. 2007. PMID: 17148938 Clinical Trial.

2

Citalopram decreases desirability, liking, and consumption of alcohol in alcohol-dependent drinkers.

Naranjo CA, Poulos CX, Bremner KE, Lanctôt KL. Naranjo CA, et al. Among authors: lanctot kl. Clin Pharmacol Ther. 1992 Jun;51(6):729-39. doi: 10.1038/clpt.1992.85. Clin Pharmacol Ther. 1992. PMID: 1535302 Clinical Trial.

3

Ritanserin, a central 5-HT2 antagonist, in heavy social drinkers: desire to drink, alcohol intake and related effects.

Naranjo CA, Poulos CX, Lanctôt KL, Bremner KE, Kwok M, Umana M. Naranjo CA, et al. Among authors: lanctot kl. Addiction. 1995 Jul;90(7):893-905. doi: 10.1046/j.1360-0443.1995.9078933.x. Addiction. 1995. PMID: 7663312 Clinical Trial.

4

Fluoxetine attenuates alcohol intake and desire to drink.

Naranjo CA, Poulos CX, Bremner KE, Lanctot KL. Naranjo CA, et al. Among authors: lanctot kl. Int Clin Psychopharmacol. 1994 Sep;9(3):163-72. doi: 10.1097/00004850-199409000-00004. Int Clin Psychopharmacol. 1994. PMID: 7814825 Clinical Trial.

5

Effects of citalopram and a brief psycho-social intervention on alcohol intake, dependence and problems.

Naranjo CA, Bremner KE, Lanctôt KL. Naranjo CA, et al. Among authors: lanctot kl. Addiction. 1995 Jan;90(1):87-99. doi: 10.1046/j.1360-0443.1995.9018712.x. Addiction. 1995. PMID: 7888983 Clinical Trial.

6

From transmitters to treatment: the pharmacotherapy of behavioural disturbances in dementia.

Herrmann N, Lanctôt KL. Herrmann N, et al. Among authors: lanctot kl. Can J Psychiatry. 1997 Jun;42 Suppl 1:51S-64S. Can J Psychiatry. 1997. PMID: 9220129 Review.

7

The efficacy, safety and tolerability of antidepressants in late life depression: a meta-analysis.

Mittmann N, Herrmann N, Einarson TR, Busto UE, Lanctôt KL, Liu BA, Shulman KI, Silver IL, Narango CA, Shear NH. Mittmann N, et al. Among authors: lanctot kl. J Affect Disord. 1997 Dec;46(3):191-217. doi: 10.1016/s0165-0327(97)00107-9. J Affect Disord. 1997. PMID: 9547117

8

Efficacy and safety of neuroleptics in behavioral disorders associated with dementia.

Lanctôt KL, Best TS, Mittmann N, Liu BA, Oh PI, Einarson TR, Naranjo CA. Lanctôt KL, et al. J Clin Psychiatry. 1998 Oct;59(10):550-61; quiz 562-3. doi: 10.4088/jcp.v59n1010. J Clin Psychiatry. 1998. PMID: 9818639

9

Effectiveness of gabapentin for the treatment of behavioral disorders in dementia.

Herrmann N, Lanctôt K, Myszak M. Herrmann N, et al. J Clin Psychopharmacol. 2000 Feb;20(1):90-3. doi: 10.1097/00004714-200002000-00015. J Clin Psychopharmacol. 2000. PMID: 10653214 Clinical Trial.

10

Donepezil for behavioural disorders associated with Lewy bodies: a case series.

Lanctôt KL, Herrmann N. Lanctôt KL, et al. Int J Geriatr Psychiatry. 2000 Apr;15(4):338-45. doi: 10.1002/(sici)1099-1166(200004)15:4<338::aid-gps119>3.0.co;2-u. Int J Geriatr Psychiatry. 2000. PMID: 10767734

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results